Biography

Ms. Ramita Tandon leads ICON Commercialisation and Outcomes, the industry leading provider of services to help life science companies achieve market authorisation, accelerate market access, and drive market adoption. ICON Commercialisation and Outcomes delivers resources and expertise to generate and analyse real world evidence and communicate treatment safety and value to help regulators, payers, providers and patients make informed health decisions. With over two and a half decades in the drug development industry, Ms. Tandon, is a recognised executive leader for her success in broadening boundaries, innovation, and architecting lean and efficient organizational models organically and through M&A activity. Ms. Tandon is known for her dynamic and engaging leadership encouraging teams to think more provocatively and to develop innovative solutions integrating expertise across the R&D landscape and through a treatment’s entire lifecycle to optimize biopharmaceuticals’ product value. Ms. Tandon is a sought after speaker, author and thought leader with regular industry commentary on the life-sciences industry and a member of the board of the Not-for–Profit Mapi Research Trust.